Literature DB >> 1084460

Detection of cytotoxic lymphoid spleen cells from STU-mice with Moloney sarcoma by a 3H-proline microcytotoxicity assay.

E Weiland, M Mussgay.   

Abstract

A microcytoxicity assay with 3H-proline prelabeled target cells was used for the detection of sensitized lymphoid spleen cells from STU inbred mice inoculated with Moloney sarcoma virus (MSV-M) or ascitic MSV-M tumor cells. The target cell line was derived from ascitic MSV-M tumor cells. With regard to the specificity of the assay nonimmune slpeen cells displayed no or only a weak cytotoxicity against these cells, and this was also the case when 3H-proline-labeled secondary cultures of syngeneic mouse embryo cells were exposed to both sensitized and nonimmune spleen cells. The time-course pattern of the development of cytotoxic lymphoid spleen cells in STU mice inoculated intramuscularly either with MSV-M or ascitic MSV-M tumor cells was studied. At the stages of tumor development, peak tumor size, and tumor regression the lymphoid spleen cell preparations were found to have relatively strong cytotoxic activity independent of whether the tumor was induced by MSV-M inoculation or tumor cell transplantation. However, in the latter case effector cells appeared earlier and were demonstrable for a longer period than in MSV-M-inoculated mice. Anti-theta serum treatment of lymphoid spleen cells taken at the stage of peak tumor size abrogated the cytotoxic activity or diminished it considerably indicating a T-lymphocyte response.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084460     DOI: 10.1007/bf02121319

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  16 in total

1.  Antitumour activity in vitro dependent on immune B lymphocytes.

Authors:  E W Lamon; H Wigzell; B Andersson; E Klein
Journal:  Nat New Biol       Date:  1973-08-15

2.  Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

3.  Production of a potent complement-fixing murine leukemia virus-antiserum from the rabbit and its reactions with various types of tissue culture cells.

Authors:  W Schäfer; E Seifert
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

4.  [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].

Authors:  E Weiland; F Weiland
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1974-11

5.  Prelabeling target cells with 3 H-proline as a method for studying lymphocyte cytotoxicity.

Authors:  M A Bean; H Pees; G Rosen; H F Oettgen
Journal:  Natl Cancer Inst Monogr       Date:  1973-06

6.  In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.

Authors:  D H Lavrin; R B Herberman; M Nunn; N Soares
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

7.  Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.

Authors:  R Kiessling; G Petranyi; G Klein; H Wigzel
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

8.  The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.

Authors:  E W Lamon; H Wigzel; E Klein; B Andersson; H M Skurzak
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

9.  Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.

Authors:  E Weiland; M Mussgay
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-11

10.  Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.

Authors:  F Plata; E Gomard; J C Leclerc; J P Levy
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

View more
  6 in total

1.  Transformed cell lines derived from progressor Sarcoma virus (Moloney) induced tumors. I. Differences in pathogenicity between C type viruses from producer and helper virus infected nonproducer cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen.

Authors:  E Weiland; F Weiland
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.

Authors:  F Weiland; E Weiland; M Mussgay
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

5.  Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions.

Authors:  Y Henin; E Gomard; S Gisselbrecht; J P Levy
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

6.  Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.

Authors:  E Weiland; M Mussgay; F Weiland
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.